Probiotics are practically synonymous with gut health in the popular imagination. Go to any health food store, wellness influencer's feed, or even most primary care waiting rooms, and you'll find the message consistent: probiotics are good for your gut. But for people with SIBO, the story is more complicated â and for some, probiotics can actively make things worse. A landmark 2018 study shed light on a disturbing phenomenon: a subset of patients with bloating, gas, and profound brain fog had been unknowingly worsening their condition with the very supplements they were taking to heal it. Understanding why requires looking at what SIBO actually is and what probiotics actually do.
The Rao 2018 Study: Brain Fog and D-Lactic Acidosis
In 2018, Dr. Satish Rao and colleagues at Augusta University published a case series in Clinical and Translational Gastroenterology examining 30 patients who presented with severe bloating, abdominal pain, and unusual neurological symptoms â specifically significant brain fog, difficulty with memory and concentration, and in some cases confusion and difficulty walking. All of these patients had been taking multi-strain probiotic supplements containing Lactobacillus species.
The researchers found that these patients had elevated D-lactic acid levels in their blood â a condition called D-lactic acidosis. This occurs when certain bacteria (particularly Lactobacillus species) ferment carbohydrates and produce D-lactic acid, which the human body metabolizes poorly. Unlike L-lactic acid (which we produce during exercise and clear efficiently), D-lactic acid crosses the blood-brain barrier and causes neurological symptoms. When researchers stopped probiotics and treated underlying SIBO, the brain fog and neurological symptoms resolved â often dramatically â within weeks.
â ī¸If you have SIBO and experience significant brain fog, confusion, or difficulty concentrating alongside your GI symptoms, your probiotic supplement may be contributing. This is not a reason to panic â stopping probiotics and discussing the Rao 2018 findings with your provider is a reasonable first step.
Why Adding More Bacteria to Bacterial Overgrowth Seems Contradictory
At the most basic mechanistic level, SIBO is defined as an abnormal increase in the number and/or type of bacteria in the small intestine. Normal small intestine bacterial counts are fewer than 10Âŗ colony-forming units per milliliter (CFU/mL). SIBO is diagnosed when counts exceed 10âĩ CFU/mL, though the threshold varies by guideline. Introducing billions of additional live bacteria through a probiotic supplement into a system already characterized by bacterial excess has a face-validity problem: you are quite literally adding to the overgrowth.
This doesn't mean probiotics always make things worse. Probiotic bacteria are different from the pathogenic or overgrown species causing problems in SIBO, and some probiotic mechanisms â competitive exclusion, immune modulation, short-chain fatty acid production â can be genuinely helpful in some contexts. But the blanket assumption that 'more bacteria equals better gut health' breaks down entirely in the context of active bacterial overgrowth in the small intestine.
Which Strains Are Most Likely to Cause Problems
Not all probiotic strains carry equal risk for SIBO patients. The strains most associated with worsening symptoms â and specifically with D-lactic acid production â are Lactobacillus species, particularly those that are high D-lactic acid producers. Multi-strain probiotics containing large amounts of Lactobacillus acidophilus, Lactobacillus fermentum, and similar species are the most commonly implicated in the Rao case series and in clinical reports.
Probiotic considerations for active SIBO:
- High D-lactic acid producers to approach cautiously: Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus delbrueckii â these are among the most common strains in commercial probiotics
- Histamine-producing strains that may worsen symptoms in histamine-sensitive SIBO patients: Lactobacillus casei, Lactobacillus reuteri, Lactobacillus bulgaricus
- Bifidobacterium species: generally lower risk than Lactobacillus, but still potentially fermentative in active SIBO
- Saccharomyces boulardii: a yeast-based probiotic, not a bacterium, that many SIBO experts consider safe and potentially beneficial even during active SIBO and antibiotic treatment
- Spore-forming probiotics (Bacillus subtilis, Bacillus coagulans): survive transit, tend to colonize the colon rather than the small intestine, may be better tolerated during active SIBO
âšī¸Histamine intolerance is common in SIBO patients because bacterial overgrowth can impair the production of diamine oxidase (DAO), the enzyme that breaks down histamine. Some Lactobacillus species both produce histamine and degrade DAO, creating a double burden for susceptible patients.
The Histamine Connection
Beyond D-lactic acid, histamine is a second mechanism through which probiotics can worsen SIBO symptoms. Histamine-producing bacteria convert the amino acid histidine (abundant in protein-containing foods) into histamine. In a healthy gut with intact mucosal enzyme function, histamine is degraded by DAO before it can cause symptoms. But SIBO damages the intestinal lining, impairs DAO production, and simultaneously introduces more histamine-producing bacterial activity â creating the conditions for histamine intolerance symptoms: flushing, headaches, hives, heart palpitations, and worsened GI symptoms.
Adding a probiotic containing Lactobacillus casei or Lactobacillus reuteri â both known histamine producers â into this environment can significantly worsen symptoms that a SIBO patient may be attributing to their diet or their condition, not realizing the supplement is the culprit. If you have SIBO and are experiencing symptoms consistent with histamine intolerance, examining your probiotic's strain profile is a worthwhile step.
When Probiotics ARE Appropriate for SIBO
The research on probiotics and SIBO does not lead to a blanket 'never take probiotics' conclusion. Timing, strain selection, and treatment phase matter enormously. Post-treatment â after completing a course of antibiotics or herbal antimicrobials â strategically selected probiotics can help re-establish a healthy microbiome, prevent opportunistic pathogens from colonizing the cleared small intestine, and reduce the risk of recurrence.
During active SIBO treatment, Saccharomyces boulardii is the most evidence-supported option. As a yeast rather than a bacterium, S. boulardii is not affected by antibacterial treatments (including rifaximin), does not contribute to D-lactic acid production, and has demonstrated benefits in preventing antibiotic-associated diarrhea, reducing Clostridioides difficile risk, and supporting mucosal immune function. Multiple SIBO-focused clinicians include S. boulardii as a standard part of treatment protocols.
Evidence-supported probiotic approaches for SIBO patients:
- During active treatment: Saccharomyces boulardii (250â500 mg, twice daily) is generally considered safe and potentially beneficial
- Post-treatment reintroduction: Start with Bifidobacterium-dominant products before adding Lactobacillus strains, at lower doses than typical supplementation
- Spore-based probiotics (Megasporebiotic, others): May be better tolerated during active SIBO due to their tendency to colonize the colon rather than the small intestine
- Avoid high D-lactic acid-producing Lactobacillus strains during active SIBO, especially if experiencing brain fog or neurological symptoms
- Soil-based organisms (SBOs): Preliminary evidence suggests tolerability in SIBO, but robust clinical data is still limited
Practical Guidance: How to Tell If Your Probiotic Is Making Things Worse
The clearest way to assess whether your probiotic is contributing to your symptoms is an elimination trial: stop the probiotic entirely for two to four weeks and track your symptoms carefully. Use a symptom tracking tool (like GLP1Gut) to log bloating, gas, brain fog, bowel habit changes, and any other symptoms daily. If you notice meaningful improvement after stopping the probiotic, that's clinically significant information â not proof, but strong enough to inform a conversation with your provider.
Look at the strain profile of any probiotic you're considering. Multi-strain products dominated by Lactobacillus acidophilus, L. casei, or L. fermentum are the highest-risk choices for active SIBO. Products containing only Bifidobacterium strains, spore-forming organisms, or S. boulardii are generally lower risk. And remember: more strains and higher CFU counts are not automatically better. For SIBO patients, a targeted, lower-dose approach with carefully selected strains is usually preferable to a 'kitchen sink' mega-probiotic.
âšī¸The nuanced answer on probiotics and SIBO is this: the right probiotic, at the right time, in the right phase of treatment, can be helpful. The wrong probiotic, or any probiotic during active overgrowth without careful selection, can make you measurably worse. Strain specificity matters more for SIBO patients than for any other population.
**Disclaimer:** This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new treatment or making changes to your existing treatment plan.